Combimist L Inhaler
Bronchospasm, Asthma
50mcg + 20mcg
Designed to support bronchodilation to manage obstructive airway episodes and alleviate physical breathing distress.
From$42.33/ inhalerView
Levosalbutamol
Levosalbutamol, called levalbuterol in US medicine sources, is a short-acting beta2 agonist bronchodilator. Levolin represents the ingredient alone, while Combimist L combines it with ipratropium in a second inhaler identity.
Levolin Inhaler
Bronchospasm, Asthma
50mcg
Indicated to address acute bronchoconstriction to relieve wheezing spasms and support easy respiration.
From$19.00/ inhalerView
Key points
- Levosalbutamol and levalbuterol are names used for the active R-enantiomer of salbutamol.
- Its beta2 agonist action relaxes airway smooth muscle.
- Combimist L adds ipratropium, an anticholinergic bronchodilator, to levosalbutamol.
Single and combination inhalers
Levolin links the ingredient directly with bronchospasm and asthma. Combimist L adds ipratropium, which reduces cholinergic airway constriction through a different receptor pathway. Reading the full ingredient line distinguishes the combination from the single-ingredient inhaler.
Bronchodilator safety context
Levalbuterol labels describe paradoxical bronchospasm and cardiovascular effects such as a faster heart rate as material risks. These facts belong to the active medicine and inhaled route; they are more informative here than repeating the numerical inhaler strengths already shown in the catalogue.